A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF)
Status
Conditions
Details and patient eligibility
About
The purpose of this observational study is to identify participants with both minor and major bleeds as a result of anticoagulant treatment for AF and evaluating their QoL through both primary and secondary care settings.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
- Adult patients (>= 18 years old)
- Patients who can understand all study information and literature to provide fully informed consent
- Atrial fibrillation (AF) as the primary diagnosis
- Having a major or minor bleed up to a maximum of 30 days prior to point of enrolment
- Receiving oral anticoagulation therapy for AF
Exclusion Criteria:
- Pregnant women
- Patients with active cancer
- Patients unable to consent for themselves
- Patient on concomitant antiplatelet therapy
Trial design
50 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Recruiting sites have contact information. Please contact the sites directly. If there is no contact information,; First line of the email MUST contain NCT # and Site #.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal